NMS

NMS
Name	Neuroleptic Malignant Syndrome
Synonyms	Malignant syndrome; Neuroleptic-induced hyperpyrexia
Specialty	Psychiatry; Neurology; Emergency department
Symptoms	Rigidity, hyperthermia, autonomic instability, altered consciousness
Onset	Typically days to weeks after antipsychotic initiation or dose change
Causes	Dopamine D2 receptor antagonists; withdrawal of dopaminergic agents
Risks	High-potency Haloperidol use, depot preparations, dehydration, agitation
Diagnosis	Clinical; elevated creatine kinase, leukocytosis, myoglobinuria
Treatment	Immediate cessation of offending agent, supportive care, dantrolene, bromocriptine
Frequency	Rare; increased risk in inpatient psychiatric populations

NMS

Neuroleptic Malignant Syndrome is an acute, life-threatening iatrogenic syndrome classically associated with dopamine antagonist exposure. It presents with a tetrad of lead-pipe rigidity, hyperthermia, autonomic dysregulation, and altered mental status and requires rapid recognition and multidisciplinary care. Early identification and treatment significantly reduce mortality that historically paralleled severe complications seen in Sepsis, Heat stroke, and fulminant Rhabdomyolysis.

Definition and Nomenclature

Neuroleptic Malignant Syndrome was first characterized following widespread use of first-generation antipsychotics and has been described in association with many agents across psychopharmacology, including Haloperidol, Chlorpromazine, and newer agents described in literature alongside Risperidone and Clozapine. Terminology has included "malignant syndrome" in reports from forensic pathology and case series in journals from centers such as Johns Hopkins Hospital and Mayo Clinic. Diagnostic criteria were proposed in consensus statements influenced by publications from the American Psychiatric Association and guidelines from organizations like the World Health Organization pharmacovigilance program.

Clinical Presentation and Diagnosis

Patients typically present after exposure to antipsychotic agents used in settings ranging from inpatient units at Bellevue Hospital to outpatient clinics affiliated with Massachusetts General Hospital. Common features include severe "lead-pipe" rigidity noted on exam, high fever often >38.5 °C, fluctuating blood pressure and tachycardia that may require involvement of intensive care units at centers such as Cleveland Clinic, and altered consciousness up to coma necessitating consultation with teams from Stanford Health Care and UCLA Health. Laboratory hallmarks are markedly elevated creatine kinase, myoglobinuria risking acute kidney injury treated in nephrology services at institutions like Toronto General Hospital, leukocytosis, and metabolic acidosis. Diagnosis relies on clinical criteria from case series reported in journals like The Lancet and New England Journal of Medicine and must be differentiated from syndromes described by Haldol-era observations and modern case reports from multicenter registries.

Pathophysiology and Etiology

Pathophysiology centers on acute dopamine D2 receptor blockade in nigrostriatal and hypothalamic pathways, paralleling mechanistic discussions in neuropharmacology texts that reference receptor models used at laboratories such as Rockefeller University and Salk Institute. The resulting dopaminergic hypofunction produces extrapyramidal rigidity, thermoregulatory failure, and autonomic instability described in physiological studies from Harvard Medical School and University College London. Predisposing etiologies include exposure to high-potency agents like Fluphenazine and intramuscular depot formulations used in long-term care at systems including Veterans Health Administration, as well as abrupt withdrawal of dopaminergic therapies used in Parkinson's disease management pioneered at centers like Mayo Clinic and described by clinicians associated with Michael J. Fox Foundation-funded research.

Differential Diagnosis

Key differentials include Serotonin syndrome often linked to agents discussed in case series from Johns Hopkins Hospital and antidepressant literature involving Fluoxetine and Serotonin-norepinephrine reuptake inhibitors; Malignant hyperthermia described in anesthesiology texts and associated with Halothane and succinylcholine exposure during surgeries at institutions like Cleveland Clinic; severe Sepsis evaluated in protocols from Centers for Disease Control and Prevention; and severe withdrawal states described in addiction medicine literature from Hazelden and Addiction Research Center reports. Neurologic mimics such as acute Parkinsonism crises, catatonia as detailed in psychiatric monographs from Royal College of Psychiatrists, and heat stroke in emergency medicine collections must also be considered.

Management and Treatment

Immediate steps mirror protocols taught in emergency medicine curricula at Johns Hopkins Hospital and involve discontinuation of offending antipsychotics, aggressive supportive care with cooling and hemodynamic stabilization in intensive care units exemplified by Mayo Clinic protocols, and monitoring for complications such as rhabdomyolysis requiring renal replacement therapy as provided by nephrology services at Mount Sinai Hospital. Specific pharmacologic therapies include the muscle relaxant dantrolene sodium developed following work at University of Minnesota and dopamine agonists such as bromocriptine referenced in psychopharmacology trials from Columbia University. Adjunctive measures may involve benzodiazepines for severe agitation as in emergency department guidelines from Society of Critical Care Medicine and electroconvulsive therapy in refractory cases reported by psychiatry centers such as Massachusetts General Hospital.

Prognosis and Complications

With prompt recognition and treatment the prognosis has improved compared with historical series from early antipsychotic eras documented in reviews from British Medical Journal and Annals of Internal Medicine. Potential complications include acute renal failure from myoglobinuria seen in nephrology cohorts at Johns Hopkins Hospital, pulmonary embolism described in case reports from Cleveland Clinic, disseminated intravascular coagulation reported in intensive care literature, and permanent neurologic sequelae discussed in long-term follow-up studies from institutions like University of California, San Francisco. Mortality in modern series is substantially lower but remains a concern in delayed or refractory cases managed in tertiary centers such as Toronto General Hospital.

Category:Neuropsychiatric syndromes